Sale!

MT-ND5 Gene Mitochondrial Complex I Deficiency Genetic Test

Original price was: $700.Current price is: $500.

-29%

The MT-ND5 Gene Mitochondrial Complex I Deficiency NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the MT-ND5 gene responsible for mitochondrial complex I deficiency. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to detect genetic abnormalities that disrupt cellular energy production, leading to severe neurological and metabolic disorders. The test is crucial for individuals experiencing unexplained neurological symptoms, developmental delays, muscle weakness, or metabolic abnormalities. By providing precise genetic information, this test enables accurate diagnosis, personalized treatment strategies, and informed family planning decisions. Available for only $500 USD, this advanced genetic analysis offers peace of mind and clear diagnostic direction for patients and families affected by mitochondrial disorders.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

MT-ND5 Gene Mitochondrial Complex I Deficiency NGS Genetic DNA Test

Comprehensive Introduction to Mitochondrial Complex I Deficiency Testing

The MT-ND5 Gene Mitochondrial Complex I Deficiency NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for mitochondrial disorders. Mitochondrial complex I deficiency is a severe inherited condition that affects the body’s ability to produce cellular energy, leading to progressive neurological deterioration and multi-system involvement. This advanced test specifically targets the MT-ND5 gene, which encodes a critical subunit of complex I in the mitochondrial respiratory chain.

Mitochondrial diseases affect approximately 1 in 5,000 individuals worldwide, making accurate diagnosis essential for proper management and treatment. The MT-ND5 gene mutation is particularly significant as it accounts for a substantial portion of mitochondrial complex I deficiency cases. Early and precise identification through this NGS-based test can dramatically impact patient outcomes and quality of life.

What This Advanced Genetic Test Detects

The MT-ND5 Gene Mitochondrial Complex I Deficiency NGS Genetic DNA Test employs sophisticated Next-Generation Sequencing technology to comprehensively analyze the entire MT-ND5 gene sequence. This test specifically identifies:

  • Point mutations in the MT-ND5 mitochondrial gene
  • Deletions and insertions affecting gene function
  • Pathogenic variants disrupting complex I assembly
  • Heteroplasmic mutations with varying tissue distribution
  • Novel genetic alterations not previously documented

Complex I deficiency results from impaired electron transport chain function, leading to reduced ATP production and increased oxidative stress. The MT-ND5 gene encodes NADH dehydrogenase subunit 5, a crucial component of complex I that facilitates the transfer of electrons from NADH to ubiquinone.

Who Should Consider This Genetic Test

This comprehensive genetic test is recommended for individuals presenting with symptoms suggestive of mitochondrial disorders, including:

Primary Clinical Indications

  • Unexplained neurological deterioration in childhood or adulthood
  • Progressive muscle weakness and exercise intolerance
  • Developmental delays and regression in motor skills
  • Seizures and epileptic encephalopathy
  • Vision and hearing loss of unknown origin
  • Metabolic acidosis and lactic acidosis
  • Cardiomyopathy and cardiac conduction defects
  • Family history of mitochondrial disorders

Specific Patient Populations

  • Children with Leigh syndrome or Leigh-like syndrome
  • Patients with MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes)
  • Individuals with unexplained multisystem involvement
  • Patients with suspected mitochondrial disease based on biochemical testing

Significant Benefits of MT-ND5 Genetic Testing

Undergoing the MT-ND5 Gene Mitochondrial Complex I Deficiency NGS Genetic DNA Test provides numerous critical advantages for patients and healthcare providers:

Diagnostic Clarity and Precision

  • Provides definitive molecular diagnosis for complex neurological conditions
  • Eliminates diagnostic uncertainty and reduces diagnostic odyssey
  • Enables targeted treatment approaches based on specific genetic findings
  • Facilitates accurate prognosis and disease progression monitoring

Family Planning and Genetic Counseling

  • Informs reproductive decisions and family planning strategies
  • Enables prenatal testing and preimplantation genetic diagnosis
  • Identifies at-risk family members for early intervention
  • Provides comprehensive genetic counseling based on precise results

Clinical Management Optimization

  • Guides appropriate therapeutic interventions and medication selection
  • Helps avoid unnecessary or potentially harmful treatments
  • Supports enrollment in clinical trials and research studies
  • Enables personalized surveillance for disease complications

Understanding Your Test Results

Interpreting MT-ND5 genetic test results requires specialized expertise in mitochondrial genetics. Our comprehensive reporting includes:

Result Interpretation Framework

  • Positive Result: Identification of a known pathogenic mutation or likely pathogenic variant in the MT-ND5 gene confirms mitochondrial complex I deficiency diagnosis.
  • Negative Result: No pathogenic variants detected in the MT-ND5 gene, though other genetic causes should be considered.
  • Variant of Uncertain Significance (VUS): Identification of genetic changes with unknown clinical significance requiring further evaluation.
  • Heteroplasmy Level: Quantitative assessment of mutation load, which correlates with disease severity and tissue involvement.

Clinical Correlation and Follow-up

All results are interpreted in the context of clinical presentation, family history, and additional diagnostic findings. Our genetic counseling team provides comprehensive result explanation and develops personalized management plans based on specific genetic findings.

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $500
Regular Price $700

Test Specifications

  • Test Name: MT-ND5 Gene Mitochondrial Complex I Deficiency NGS Genetic DNA Test
  • Turnaround Time: 3 to 4 Weeks
  • Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
  • Methodology: Next-Generation Sequencing (NGS) Technology
  • Specialty: Neurological Genetics

Pre-test Requirements

Prior to testing, we recommend:

  • Comprehensive clinical history documentation
  • Genetic counseling session with pedigree analysis
  • Review of previous diagnostic testing results
  • Discussion of potential implications and limitations

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures accessible testing for patients nationwide.

Take Action Today for Genetic Clarity

Don’t let diagnostic uncertainty delay proper care and management. The MT-ND5 Gene Mitochondrial Complex I Deficiency NGS Genetic DNA Test provides the definitive answers needed for effective treatment planning and family guidance. Our team of genetic specialists and neurologists are ready to support you through every step of the testing process.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Early diagnosis can make a significant difference in managing mitochondrial disorders and improving quality of life.

Take the first step toward genetic clarity and personalized medical management. Contact us now to learn more about this advanced diagnostic test and how it can benefit you or your loved one.